Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A

MT Newswires Live

2024/09/10

Shanghai Fosun Pharmaceutical (Group) (HKG:2196) said its unit's Botulinum Toxin Type A for Injection application for new drug registration was approved by China's National Medical Products Administration (NMPA), according to a Monday filing with the Hong Kong bourse.

The drug is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator or procerus muscle activity in adult patients.

The pharmaceutical company's stocks were down by nearly 1% at Tuesday's closing.

Price (HKD): $11.78, Change: $-0.060, Percent Change: -0.51%

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2466852234"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2466852234\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2466852234?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-10 16:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2466852234","market":"sh","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A","media":"MT Newswires Live","content":"<html><body><p>Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A</p><p> Shanghai Fosun Pharmaceutical (Group) (HKG:2196) said its unit's Botulinum Toxin Type A for Injection application for new drug registration was approved by China's National Medical Products Administration (NMPA), according to a Monday filing with the Hong Kong bourse.</p><p>The drug is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator or procerus muscle activity in adult patients.</p><p>The pharmaceutical company's stocks were down by nearly 1% at Tuesday's closing.</p><p>Price (HKD): $11.78, Change: $-0.060, Percent Change: -0.51%</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-10 16:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A Shanghai Fosun Pharmaceutical (Group) (HKG:2196) said its unit's Botulinum Toxin Type A for Injection ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0183","symbol_name":"MSCI概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2466852234","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466852234","pubTimestamp":1725957749,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A Shanghai ","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","BK0183":"MSCI概念","BK4588":"碎股","BK0188":"融资融券","BK1593":"医美概念股","BK0012":"证金概念","HKD":"尚乘数科","BK0187":"一线龙头","02196":"复星医药","BK0028":"国家队","00656":"复星国际","BK0175":"白马股","BK0060":"抗癌","BK1191":"制药","BK4023":"应用软件","BK4585":"ETF&股票定投概念","BK0196":"行业龙头","BK1515":"抗疫概念","BK4526":"热门中概股","NHLD":"National Holdings Corporation","BK0239":"医药制造","BK0096":"民营医院"},"translate_title":"上海复星医药A型肉毒杆菌毒素获得中国药品监管机构认可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"00656":1,"NHLD":1,"HKD":1,"02196":1},"content_text":"Shanghai Fosun Pharmaceutical Gets Chinese Drug Regulator's Nod for Botulinum Toxin Type A Shanghai Fosun Pharmaceutical (Group) (HKG:2196) said its unit's Botulinum Toxin Type A for Injection application for new drug registration was approved by China's National Medical Products Administration (NMPA), according to a Monday filing with the Hong Kong bourse.The drug is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator or procerus muscle activity in adult patients.The pharmaceutical company's stocks were down by nearly 1% at Tuesday's closing.Price (HKD): $11.78, Change: $-0.060, Percent Change: -0.51%","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}